Analyzing Guardian Pharmacy Services (GRDN) and Its Rivals

Guardian Pharmacy Services (NYSE:GRDN) is one of 233 public companies in the “Healthcare Providers & Services” industry, but how does it compare to its peers? We will compare Guardian Pharmacy Services to similar businesses based on the strength of its institutional ownership, analyst recommendations, risk, valuation, dividends, profitability and earnings.

Institutional and Insider Ownership

56.7% of shares of all “Healthcare Providers & Services” companies are owned by institutional investors. 33.0% of Guardian Pharmacy Services shares are owned by company insiders. Comparatively, 15.0% of shares of all “Healthcare Providers & Services” companies are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Profitability

This table compares Guardian Pharmacy Services and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Guardian Pharmacy Services	N/A	N/A	N/A
Guardian Pharmacy Services Competitors	142.35%	-0.16%	-4.98%

Risk & Volatility

Guardian Pharmacy Services has a beta of 0.03, suggesting that its stock price is 97% less volatile than the S&P 500. Comparatively, Guardian Pharmacy Services’ peers have a beta of 1.10, suggesting that their average stock price is 10% more volatile than the S&P 500.

Earnings and Valuation

This table compares Guardian Pharmacy Services and its peers revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Guardian Pharmacy Services	$1.46 billion	N/A	38.44
Guardian Pharmacy Services Competitors	$1.66 billion	$11.00 million	7.08

Guardian Pharmacy Services’ peers have higher revenue and earnings than Guardian Pharmacy Services. Guardian Pharmacy Services is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.

Analyst Ratings

This is a breakdown of current ratings for Guardian Pharmacy Services and its peers, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Guardian Pharmacy Services	0	1	9	0	2.90
Guardian Pharmacy Services Competitors	1837	7671	13197	813	2.55

Guardian Pharmacy Services presently has a consensus target price of $45.57, indicating a potential upside of 15.11%. As a group, “Healthcare Providers & Services” companies have a potential upside of 12.65%. Given Guardian Pharmacy Services’ stronger consensus rating and higher possible upside, research analysts plainly believe Guardian Pharmacy Services is more favorable than its peers.

Summary

Guardian Pharmacy Services beats its peers on 7 of the 12 factors compared.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs. The company was founded in 2003 and is based in Atlanta, Georgia.